✦ LIBER ✦

Brief communication: Use of the multitargeted antifolate pemetrexed (Alimta) in genitourinary cancer

✍ Scribed by Jean-Louis Misset

Book ID: 114481172
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 64 KB
Volume: 29
Category: Article
ISSN: 0093-7754
DOI: 10.1053/sonc.2002.30748

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Induction of resistance to the multitarg

Induction of resistance to the multitargeted antifolate Pemetrexed (ALIMTA) in WiDr human colon cancer cells is associated with thymidylate synthase overexpression

✍ Jennifer Sigmond; Harold H.J. Backus; Dorine Wouters; Olaf H. Temmink; Gerrit Ja 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Phase I and pharmacokinetic study (PK) o

Phase I and pharmacokinetic study (PK) of the combination of multitargeted antifolate pemetrexed (ALIMTA) with irinotecan (CPT-11) in patients with advanced malignancies

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 277 KB

Phase II study of pemetrexed disodium, a

Phase II study of pemetrexed disodium, a multitargeted antifolate, and cisplatin as first-line therapy in patients with advanced nonsmall cell lung carcinoma : A study of the national cancer institute of Canada clinical trials group

✍ Frances A. Shepherd; Janet Dancey; Andrew Arnold; Alan Neville; James Rusthoven; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 3 views

## Background: Pemetrexed disodium (alimta [eli lilly and company, indianapolis, in], ly231514, multitargeted antifolate) is a new multitargeted antifolate agent that inhibits multiple enzymes in the folate pathway. phase ii trials showed single-agent response rates of 16% and 23% in untreated pati